The Eurofins Network Expands Its Offering in Renal and Transplant Testing in the United States With the Acquisition of Ascend Clinical LLC



Eurofins Scientific (EUFI.PA), a global leader in bioanalytical testing, has announced the closing of its acquisition of Ascend Clinical, LLC (Ascend), the largest independent renal testing laboratory in the United States. Founded in 2000, Ascend operates a state-of-the-art laboratory in Sunnyvale, California and employs 170 people. The company provides diagnostic chemistry, hematology, microbiology and virology testing services to dialysis clinics and hospitals in the United States. The company also offers water and dialysate testing, providing greater safety for dialysis patients and improving diagnostic and diagnostic quality. Ascend’s proven expertise in customer relations leverages the vast majority of Eurofins’ network in both pre- and post-service operations, resulting in better and greater customer support.

The acquisition also strengthens the Eurofins network’s focus on third-party testing and kidney-related care, and expands its clinical customer base. Ascend, in return, gains access to Eurofins’ network of laboratories, analytical portfolio, and established industry relationships. Patti Hunsader, Ascend’s current COO, will assume the role of President of Ascend Clinical. The company’s existing management will remain in place, continuing to drive the organization’s growth as part of Eurofins’ business line in the United States.

Comment from Dr. Gilles Martin, CEO of Eurofins: “This project continues to strive to provide best-in-class diagnostic services to patients in the kidney and transplant fields. and to help Ascend strengthen and expand the important services it provides to patients.

Comment from Patti Hunsader, Ascend COO: “We are excited to join the Eurofins network. This partnership creates exciting opportunities to use our combined skills and resources to impact the lives of the patients we serve.”

Combining Ascend’s expertise with Eurofins’ customer base and location, technology and expertise will enhance the care provided to patients across the country.

Note to Editors:

About Eurofins “a world leader in the field of analysis

Eurofins is a Life Test. Eurofins Scientific SE’s network of independent companies believes it is a global leader in food, environmental, pharmaceutical and cosmetic testing and drug discovery, forensics, advanced product science and agroscience contract research services. It is also one of the market leaders in other testing and genomics laboratories, as well as supporting clinical studies, and in biopharma collaboration and manufacturing. It also has a rapidly growing presence in specialized quantitative and qualitative cell culture and in vitro diagnostic products.

It is approx. 62,000 employees across a developed and commercial network of more than 900 laboratories in more than 1,000 companies in 62 countries, Eurofins offers a portfolio of more than 200,000 methods for evaluating safety, information, design, authenticity, origin, compliance and purity of all kinds. of products, as well as providing new clinical diagnostic and in-vitro diagnostic products.

Many of Eurofins’ corporate activities are important for the health and safety of people and our planet. The ongoing investments to digitize and maintain the best laboratory network and modern equipment support our goal of providing our customers with the highest quality services, innovative solutions and accurate results in the best turnaround time (TAT) . Eurofins companies are well-positioned to support customers who are increasingly meeting safety standards and the increasing number of regulatory requirements and requirements for healthcare providers around the world.

The Eurofins network has grown significantly since its inception and its strategy is to continue to expand its technical capabilities and reach. Through R&D and acquisitions, its companies adopt the latest developments in biological sciences and analytical chemistry to provide their customers with unique analytical solutions.

Eurofins Scientific SE shares are listed on the Euronext Paris Stock Exchange (ISIN FR0014000MR3, Reuters EUFI.PA, Bloomberg ERF FP).

About the Ride

Ascend Clinical was founded in Northern California in 2000 as a clinical laboratory specializing in kidney disease testing. Ascend’s commitment to superior technology and innovative solutions has expanded their services to cover a wide variety of eye diseases. With a state-of-the-art laboratory located in Sunnyvale, CA, and offices in Colorado, Ascend is one of the largest independent laboratories in the United States, dedicated to helping physicians and improving patient care. More at

For more information, please visit or contact:
Investor Relations
Concept of the company Eurofins Scientific SE
Phone: +32 2 766 1620

Source: Eurofins Scientific

!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;n.queue=[];t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,’script’,’’);


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *